1. Recombinant viruses as a tool for therapeutic vaccination against human cancer;Bonnet;Immunol. Lett.,2000
2. Systemic anaphylaxis in guinea-pigs: intra-laboratory validation study;Brutzkus;Fund. Appl. Toxicol.,1997
3. EMEA, 1997. Note for guidance on preclinical phamacological and toxicological testing of vaccines. CPMP/SWP/465/95.
4. EMEA, 2001. Note for Guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products. CPMP/BWP/3088/99.
5. FDA, CBER, 1996. Addendum to the points to consider in human somatic cell and gene therapy (1991).